Ozempic (semaglutide) causes gastrointestinal side effects in the majority of people who take it, with nausea being the most common. Most of these effects are mild to moderate and improve over time, but the drug also carries warnings for several serious conditions, including thyroid tumors and pancreatitis. Here’s what to expect at each level of severity.
Common Gastrointestinal Side Effects
The most frequent side effects are digestive. Nausea, vomiting, diarrhea, stomach pain, and constipation affect a significant portion of users, especially during the first weeks on the drug and after each dose increase. These symptoms happen because semaglutide slows down how quickly your stomach empties, which is part of how it reduces appetite and controls blood sugar.
Ozempic’s dosing schedule is specifically designed to minimize these effects. You start at the lowest dose (0.25 mg weekly) for four weeks before moving up to 0.5 mg, then potentially to 1 mg or 2 mg, with at least four weeks at each level. This gradual ramp-up gives your body time to adjust. For most people, nausea is worst during the first few weeks at a new dose and fades as the body adapts.
How to Manage Nausea and Stomach Issues
Simple changes to how and what you eat can make a real difference. Eating smaller meals more frequently, chewing slowly, and stopping as soon as you feel satisfied all help reduce nausea. Avoid lying down right after eating, but skip intense exercise right after meals too.
Certain foods are easier on your stomach while you’re adjusting: broth, crackers, toast, plain rice or noodles, bananas, applesauce, and cold foods like plain yogurt or popsicles. On the other hand, greasy, fried, spicy, very sweet, or strong-smelling foods tend to make nausea worse. Sipping water frequently in small amounts also helps, especially if nausea makes it hard to drink normally.
Gastroparesis Risk
Because semaglutide slows stomach emptying, there’s a concern about gastroparesis, a condition where the stomach takes far too long to move food into the small intestine. A Cleveland Clinic study using a database of roughly 88 million patients found that people with type 2 diabetes who took GLP-1 drugs like Ozempic had a significantly higher risk of being diagnosed with gastroparesis compared to those who didn’t, with elevated odds appearing at six months and persisting through two years.
Gastroparesis symptoms include persistent nausea, vomiting, bloating, and feeling full long after eating. It’s distinct from the temporary nausea most users experience. If digestive symptoms don’t improve or get worse over time rather than better, that’s worth flagging to your prescriber.
Pancreatitis and Gallbladder Problems
Acute pancreatitis, an inflammation of the pancreas that causes severe abdominal pain, is listed as a warning on the Ozempic label. Clinical trials of semaglutide specifically didn’t show higher rates of pancreatitis than placebo. However, broader studies of the GLP-1 drug class tell a more cautious story. Epidemiological research on older daily-injected GLP-1 drugs suggests roughly double the risk of acute pancreatitis compared to non-users, and one large study found a ninefold higher risk when these drugs were used for weight loss compared to other weight-loss medications. For context, acute pancreatitis affects about 1 in 2,500 adults per year at baseline.
Gallstones are another related risk. Rapid weight loss, regardless of how it happens, increases the likelihood of developing gallstones. Semaglutide may compound this by directly affecting the gallbladder. Gallstones can in turn trigger pancreatitis, creating a chain of complications. Symptoms to watch for include sudden, intense pain in the upper abdomen, pain radiating to the back, nausea with vomiting, and fever.
Thyroid Tumor Warning
Ozempic carries the FDA’s most serious label warning, a boxed warning, for thyroid tumors. In animal studies, semaglutide caused thyroid C-cell tumors at doses comparable to what humans take, and the risk increased with higher doses and longer treatment. Whether this translates to humans remains unknown.
Because of this uncertainty, Ozempic is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or a condition called multiple endocrine neoplasia syndrome type 2. The FDA notes that routine screening with blood tests or thyroid ultrasounds isn’t recommended for most users because these tests have high false-positive rates and could lead to unnecessary procedures. Instead, be aware of potential symptoms: a lump or mass in your neck, difficulty swallowing, shortness of breath, or persistent hoarseness.
Diabetic Retinopathy Concerns
Early trials of semaglutide raised a signal about worsening diabetic eye disease, which prompted concern among people with diabetes. However, a large retrospective study of over 810,000 new semaglutide users found no increased risk of serious diabetic retinopathy complications compared to other diabetes medications. In fact, semaglutide users had lower rates of needing eye treatment than those on several other common diabetes drugs. The initial concern may have been related to rapid blood sugar improvements rather than the drug itself, since sharp drops in blood sugar are known to temporarily stress the blood vessels in the eyes.
Changes in Facial Appearance
“Ozempic face” has become a widely discussed cosmetic concern. It refers to a gaunt, hollow look in the face and neck, with sagging skin, sunken cheeks, and new wrinkles. This isn’t a direct pharmacological effect of semaglutide. It’s a consequence of rapid weight loss.
Your face gets its shape partly from subcutaneous fat, the layer of fat just beneath the skin. When you lose weight quickly, that facial fat shrinks faster than the overlying skin can adjust. Rapid weight loss also lowers your skin’s levels of collagen and elastin, the two proteins responsible for keeping skin firm and stretchy. The result is loose, sagging skin that makes someone look older or more hollow than they did before. This effect is more pronounced with larger amounts of weight loss and in older adults, whose skin has less elasticity to begin with. Slower, more gradual weight loss reduces the severity.
Muscle Loss and Body Composition
Any significant calorie reduction leads to some muscle loss alongside fat loss, and semaglutide is no exception. Clinical data suggest that roughly 25 to 40 percent of the weight people lose on GLP-1 drugs can come from lean mass rather than fat. This matters because muscle supports your metabolism, joint stability, and overall physical function, especially as you age.
Strength training and adequate protein intake are the most effective ways to preserve muscle while on Ozempic. Prioritizing protein at every meal helps signal your body to maintain muscle tissue even during a calorie deficit.
Other Side Effects Worth Knowing
Beyond the GI and serious risks, users sometimes report fatigue, headache, dizziness, and injection-site reactions like redness or irritation. These tend to be mild. Some people also experience changes in taste or a general loss of interest in food that goes beyond simple appetite suppression.
Ozempic can cause low blood sugar when combined with insulin or certain other diabetes medications, though it rarely does so on its own. Symptoms include shakiness, sweating, confusion, and rapid heartbeat. If you’re on multiple diabetes drugs, your prescriber may need to adjust the doses of your other medications as semaglutide takes effect. Serious allergic reactions, including swelling of the face and difficulty breathing, have been reported but are rare. The drug is contraindicated for anyone with a known hypersensitivity to semaglutide.